Document is current
Any future updates will be listed below
-
Authors
Hoffer, Barry J.
Pick, Chaim G.
Hoffer, Michael E.
Becker, Robert E.
Chiang, Yung-Hsiao
Greig, Nigel H.
-
Funding
Funding for this research was provided by:
US Public Health Service
U.S. Department of Defense
Taipei Medical University
US Public Health Service
The Sackler School of Medicine, Tel-Aviv University
- License Information
-
More Information
Article History
Received: 20 April 2017
Accepted: 30 August 2017
First Online: 9 September 2017
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Robert E. Becker does not have a competing interest but a conflict of interest. For disclosure, Robert E. Becker holds a patent on the use of phenserine in concussion/TBI and Alzheimer’s disease assigned to Aristea Translational Medicine Corporation of Utah. None of the other authors have any competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
